Skip to main content
National Organization for Rare Disorders (NORD) avatar

National Organization for Rare Disorders (NORD)

@raredisorders

7,930

Prenumeratoriai

Advertisement
PostWhatsAppReddit
Advertisement

peržiūros

1,052,976

Vaizdo įrašai

538

API

7,930

8K

70
Advertisement

Gyvas YouTube prenumeratorių skaitiklis

Loading Advanced Analytics...

Advertisement

National Organization for Rare Disorders (NORD)

The National Organization for Rare Disorders® (NORD®) is the leading independent, nonpartisan, nonprofit organization dedicated to improving the health and lives of over 30 million Americans living with more than 10,000 different rare diseases. In partnership with more than 350 disease-specific NORD Member patient organizations and 46 NORD Rare Disease Centers of Excellence across the country, NORD drives progress in rare disease research, care, and policy.

NORD began as a small group of patient advocates who formed a coalition to mobilize support to pass the Orphan Drug Act of 1983. For more than 40 years since, NORD has led the way in voicing the needs of the rare disease community — driving supportive state and federal policies, medical education, and patient-powered research — while also providing dedicated patient and family services for those who need them most. Learn more and get involved at rarediseases.org.

Advertisement

Embed

Stebėkite YouTube prenumeratorius, peržiūras, kūrėjų palyginimus ir tikslus realiuoju laiku.

Vaizdo įrašai

Bayesian and Adaptive Trial Designs for Ultra-Rare Populations - NORD Scientific Symposium

Uploaded

17

peržiūros

0

Likes

0

Comments

Advertisement

About RealtimeSubCount.com

Stebėkite YouTube prenumeratorius, peržiūras, kūrėjų palyginimus ir tikslus realiuoju laiku.

FAQ

Stebėkite YouTube prenumeratorius, peržiūras, kūrėjų palyginimus ir tikslus realiuoju laiku.

Stebėkite YouTube prenumeratorius, peržiūras, kūrėjų palyginimus ir tikslus realiuoju laiku.

Stebėkite YouTube prenumeratorius, peržiūras, kūrėjų palyginimus ir tikslus realiuoju laiku.